Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03374566Completed
Immunodeficiency for Severe Epstein-Barr Virus Infection
Epstein-Barr Virus InfectionsImmunodeficiency
PrincipalinvestigatorStart date: 2017-12-01
NCT03383380Phase 1/2Completed
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
Activated PI3K-delta SyndromeImmunodeficiency Primary
PrincipalinvestigatorStart date: 2017-12-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Children's Hospital of Fudan University

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03374566PrincipalInvestigator

Immunodeficiency for Severe Epstein-Barr Virus Infection

Epstein-Barr Virus InfectionsImmunodeficiency
Completed
NCT03383380Phase 1/2PrincipalInvestigator

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

Activated PI3K-delta SyndromeImmunodeficiency Primary
Completed

All 2 trials loaded